类风湿关节炎是否总是先经历有症状的关节痛高危阶段?
该研究纳入2012至2022年连续诊断的699例类风湿关节炎(RA)患者,比较直接以临床明显关节炎起病者与先表现为临床疑似关节痛(CSA)者。结果显示仅部分RA患者(两个聚类,占55%)有前驱CSA阶段,这些患者更年轻、症状渐起、ACPA阳性更多,且无改善病情抗风湿药持续缓解(SDFR)率更低(HR 0.51,95%CI 0.37至0.68)。作者认为「全部RA人群均存在可识别的症状性高危阶段」这一观念应被否定。
要点
- 699例新诊断RA中,先表现为CSA者更年轻、症状渐起且ACPA阳性更多。
- 四个聚类中两个聚类(占RA人群55%)几乎包含所有有前驱CSA的患者。
- 有前驱CSA聚类患者SDFR更少,HR 0.51(95%CI 0.37至0.68)。
核心结论
- 数据提示「全部RA人群均存在可识别的症状性高危阶段」这一观念应被否定,这可能影响针对症状性高危阶段预防干预的范围。
研究设计与样本
- 研究为2012至2022年连续诊断的RA患者起始队列,共699例,患者或直接以临床明显关节炎起病,或先表现为临床疑似关节痛(CSA)。
主要发现
- 先表现为CSA的RA患者更年轻、更常呈症状渐起且更常ACPA阳性。
- 在症状起病和RA诊断特征上发现四个患者聚类,其中两个聚类几乎包含所有有前驱CSA阶段的患者。
- 这两个聚类患者(占RA人群55%)更年轻、症状渐起、症状持续时间更长且ACPA阳性更常见。
- 这两个聚类患者达到SDFR的比例低于前驱CSA不常见/缺失的两个聚类患者,HR 0.51(95%CI 0.37至0.68)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire RA population is believed to experience a symptomatic 'pre-RA' phase. We wondered whether this dogma is correct. Therefore we investigated an inception cohort of patients with newly diagnosed RA and studied among them patients who did and did not present with preceding arthralgia at risk for RA. METHODS: Consecutively diagnosed patients with RA between 2012 and 2022 were studied (n=699). These patients had either directly presented with clinically apparent arthritis, or had first presented with clinically suspect arthralgia (CSA). Clinical characteristics at symptom onset and RA diagnosis were compared. Whether certain characteristics frequently occurred together was studied using a K-means algorithm after dimension reduction with partial least squares discriminant analysis. To validate that groups differed in long-term outcomes, sustained disease-modifying anti-rheumatic drug-free remission (SDFR) of the groups was studied during a median follow-up of 5.3 years. RESULTS: Patients with RA who had first presented with CSA were younger, more often had a gradual symptom onset and were more often anti-citrullinated protein antibodies (ACPA)-positive. Studying characteristics at symptom onset and RA diagnosis revealed four patient clusters, of which two clusters included almost all patients with a preceding CSA phase. Patients in these two clusters (55% of RA population) were younger, had a gradual symptom onset, longer symptom duration and were more frequently ACPA-positive. Patients with RA in these clusters achieved SDFR less often (HR 0.51 (95% CI 0.37 to 0.68)) than the patients with RA in the two clusters where preceding CSA was infrequent/absent. CONCLUSION: These data suggest the notion that the entire RA population has an identifiable symptomatic risk stage should be refuted. This may impact on the scope of preventive interventions targeting the symptomatic risk phase.
引用
- Claassen S, Boeren AMP, Khidir SJH, et al. Is rheumatoid arthritis always preceded by a symptomatic at-risk phase of arthralgia? RMD Open. 2024. PMID: 39537206. doi:10.1136/rmdopen-2024-004714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。